Benzodiazepine Dependence Clinical Trial
Official title:
Baclofen for Improving Benzodiazepine Titration in Benzodiazepine Dependence
Benzodiazepines and related molecules are among the most prescribed psychotropic treatments in France and Europe. 13.4% of the French population had at least one reimbursement of benzodiazepines in 2015, which places France second in Europe. However, the chronic use of benzodiazepines is a source of numerous complications, particularly addictive. To date, there is no authorized pharmacological treatment for benzodiazepine withdrawal. Baclofen is a gamma-aminobutyric acid (GABA)-B agonist, a pharmacological receptor that regulates GABA-A, the target of benzodiazepines. The pharmacological mechanisms of baclofen are therefore related to those of benzodiazepines. Empirical use outside of the MA has shown that baclofen can facilitate the reduction of benzodiazepines in cases of severe addiction, but this pharmaceutical interest remains to be demonstrated in a comparative study. The main objective of the project is to evaluate the efficacy of baclofen, compared to placebo, in reducing benzodiazepine doses in patients with benzodiazepine use disorder (BUD).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04533230 -
Prevention of Benzodiazepine Misuse in Primary Care
|
N/A | |
Completed |
NCT02127411 -
Effectiveness of Mindfulness Based Relapse Prevention for Chronic Users of Benzodiazepines
|
N/A | |
Terminated |
NCT03192514 -
Electronic Deprescribing Tool for the Prevention of PIP
|
N/A | |
Not yet recruiting |
NCT05765656 -
Effectiveness of a Joint General Practitioner-Pharmacist Intervention on Benzodiazepine Deprescribing in the Elderly
|
N/A | |
Completed |
NCT03937180 -
Blended Care for the Discontinuation of Benzodiazepine Use
|
N/A | |
Active, not recruiting |
NCT04572750 -
Promoting Benzodiazepine Cessation Through an Electronically-delivered Patient Self-management Intervention
|
N/A | |
Recruiting |
NCT02475538 -
Electroacupuncture for Tapering Off Long-term Benzodiazepine Use
|
N/A | |
Terminated |
NCT01893632 -
Gabapentin Treatment of Benzodiazepine Dependence
|
Phase 2 | |
Completed |
NCT00420771 -
Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients
|
Phase 2 | |
Recruiting |
NCT06250842 -
Benzodiazepine Impact on Cognitive Function: fNIRs and PET/MRI Study
|
||
Completed |
NCT03971097 -
The Effect of Self-Forgiveness on Self-Stigma in Addiction.
|
N/A | |
Not yet recruiting |
NCT06359314 -
Anxiety Lowering and Deprescribing Through Emotion Regulation
|
N/A |